5 Things To Know About Ai, Genomics And Personalization Of Health Care From 23andme’s Anne Wojcicki At Sxsw

Anne Wojcicki, the co-founder and CEO of 23andMe genomics profile company, discussed the potential of artificial intelligence (AI) in health care during a conversation with Bloomberg’s Emily Chang at South by Southwest. Wojcicki believes that AI will enable more personalized health care, and that it is not a question of whether to use AI, but how to use it. She also highlighted the potential of AI for prediction, such as predicting the onset of diabetes.